Skip to main content
VANI
NASDAQ Industrial Applications And Services

Vivani 10-Q: Going Concern Warning, Cash Runway Only Through Q1 2027

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.182
Mkt Cap
$101.93M
52W Low
$0.923
52W High
$1.661
52W Position info
28% above low
Off High info
29% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

VANI sits 28% above its 52-week low of $0.923.

Summary

Vivani's Q3 10-Q repeats the $7.3M quarterly loss already reported Nov 11 but adds a going-concern warning and a cash runway that now ends in Q1 2027, with all prior equity purchase agreements fully drawn.


Key Events · Earnings and Guidance · VANI

  • Going Concern Doubt Disclosed

    Management states recurring losses and negative operating cash flow raise substantial doubt about the ability to continue as a going concern for one year after issuance, and that its plans do not alleviate that doubt.

  • Cash Runway Cut to Q1 2027

    Cash and equivalents were $14.591M at September 30, 2026 versus $16.232M at December 31, 2025; the company now says existing cash funds operations only through the first quarter of 2027.

  • Equity Purchase Agreements Fully Drawn

    The three equity purchase agreements worth up to $21.2M across 19 tranches closed their final tranche on July 15, 2026, leaving no further proceeds available under them.

  • Q3 Loss Widened to $7.25M

    Three-month net loss was $7.25M versus $6.53M a year earlier, with R&D up 11% to $5.02M; nine-month net loss was $20.4M versus $19.976M.


Analysis · VANI · Industrial Applications And Services

The Q3 numbers were already out on Nov 11, but the 10-Q carries the part that matters: management states substantial doubt about the company's ability to continue as a going concern, with $14.6M of cash lasting only through Q1 2027 — a shorter runway than the Q2 10-Q's Q2 2027 estimate. The equity purchase agreements that funded 2026 are fully drawn, so the next dollar has to come from a new raise or from completing the Cortigent spin/merger into ClearOne, which is still pending and depends on ClearOne raising $10M-$15M at closing. Existing holders face further dilution if the company sells stock into a $1.18 share price.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VANI was trading at $1.18 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $101.9M. The 52-week trading range was $0.92 to $1.66. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VANI - Latest Insights

VANI
Nov 12, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $1.13 info
Change: -$0.040 (-3%) info
Market Cap: $101.93M info
VANI
Nov 11, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.13
Real-time Price: $1.13 info
Change: $0 (0%) info
Market Cap: $101.93M info
VANI
Aug 13, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.34
Real-time Price: $1.13 info
Change: -$0.210 (-16%) info
Market Cap: $101.93M info
VANI
Aug 06, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.40
Real-time Price: $1.13 info
Change: -$0.270 (-19%) info
Market Cap: $101.93M info
VANI
Jul 16, 2026, 9:00 AM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $1.41
Real-time Price: $1.13 info
Change: -$0.280 (-20%) info
Market Cap: $101.93M info